Cellectis (CLLS) Operating Expenses: 2015-2023
Historic Operating Expenses for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$22.3 million.
- Cellectis' Operating Expenses rose 23.67% to -$22.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$97.9 million, marking a year-over-year increase of 23.85%. This contributed to the annual value of $115.4 million for FY2022, which is 18.78% down from last year.
- Cellectis' Operating Expenses amounted to -$22.3 million in Q3 2023, which was up 12.91% from -$25.6 million recorded in Q2 2023.
- Cellectis' 5-year Operating Expenses high stood at -$22.3 million for Q3 2023, and its period low was -$54.8 million during Q4 2020.
- For the 3-year period, Cellectis' Operating Expenses averaged around -$34.5 million, with its median value being -$30.0 million (2022).
- As far as peak fluctuations go, Cellectis' Operating Expenses slumped by 41.22% in 2020, and later soared by 45.05% in 2022.
- Quarterly analysis of 5 years shows Cellectis' Operating Expenses stood at -$44.8 million in 2019, then dropped by 22.23% to -$54.8 million in 2020, then skyrocketed by 33.79% to -$36.3 million in 2021, then surged by 36.65% to -$23.0 million in 2022, then grew by 23.67% to -$22.3 million in 2023.
- Its Operating Expenses stands at -$22.3 million for Q3 2023, versus -$25.6 million for Q2 2023 and -$27.0 million for Q1 2023.